Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

The TEMPI syndrome

David B. Sykes, Casey O’Connell, Wilfried Schroyens

Blood (2020) 135 (15): 1199–1203.

https://doi.org/10.1182/blood.2019004216

Published: 2020

Includes: Supplemental data

Journal Articles

Incidence of Thromboembolic Disease in Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Marcelo Martin Serra, MD, Cristina Maria Elizondo, MD, Marina Alonso, MD, Veronica Peuchot, MD, Fernando Javier Vazquez, PhD

Blood (2018) 132 (Supplement 1): 4967.

https://doi.org/10.1182/blood-2018-99-112945

Published: 2018

Journal Articles

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Paulette Bryant, MD, Katie Andricopulos, PharmD, BCPPS

Blood (2017) 130 (Supplement 1): 4854.

https://doi.org/10.1182/blood.V130.Suppl_1.4854.4854

Published: 2017

Journal Articles

Causes and Severity of Anemia in Hereditary Hemorrhagic Telangiectasia

Kristy Pahl, MD, Arkopal Choudhury, Raj S. Kasthuri, MD MBBS

Blood (2016) 128 (22): 3776.

https://doi.org/10.1182/blood.V128.22.3776.3776

Published: 2016

Journal Articles

Pomalidomide in Hereditary Hemorrhagic Telangiectasia: Interim Results of a Phase I Study

Mohamed Samour, MBBS, Caner Saygin, MD, Rashid Abdallah, RN, Suman Kundu, MS, MBA, Keith R. McCrae, MD

Blood (2016) 128 (22): 210.

https://doi.org/10.1182/blood.V128.22.210.210

Published: 2016

Journal Articles

Mexican Patient with Refractory Mycosis Fungoides Successfully Treated with Pralatrexate at Low Doses: Case Report

Jose R Lopez, Hematologist

Blood (2015) 126 (23): 5068.

https://doi.org/10.1182/blood.V126.23.5068.5068

Published: 2015

Journal Articles

Histological Characteristics of Ataxia Telangiectasia Associated Lymphoproliferative Diseases. Results of the French Registry of Primary Immune Deficiencies

Danielle Canioni, MD, Nizar Mahlaoui, MD MSc, MPH, Chantal Andriamanga, MD, Catherine Dubois d'Enghien, Jean-Philippe Jais, MD PhD, Alain Fischer, MD PhD, Olivier Hermine, MD PhD, Nicole Brousse, Dominique Stoppa-Lyonnet, Felipe Suarez, MD PhD

Blood (2014) 124 (21): 1634.

https://doi.org/10.1182/blood.V124.21.1634.1634

Published: 2014

Journal Articles

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

Joan Beckman, MDPhD, Karen L Smith, BS, Samuel T Hester, MD, Ofri Leitner, MS, CGC, Raj S. Kasthuri, MD MBBS

Blood (2014) 124 (21): 1515.

https://doi.org/10.1182/blood.V124.21.1515.1515

Published: 2014

Journal Articles

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

Wilfried A. Schroyens, MD, PhD, Casey L. O'Connell, MD, Martha Q Lacy, MD, Eyal C. Attar, MD, Noopur Raje, MD, Bradley G. Somer, MD, Flavia G Rosado, MD, James Hoyer, MD, Donald I. Feinstein, MD, David B. Sykes, MD, PhD

Blood (2012) 120 (21): 986.

https://doi.org/10.1182/blood.V120.21.986.986

Published: 2012

Journal Articles

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

Carlo L Balduini, Francesca Bellistri, Fabio Pagella, Francesco Chu, Elina Matti, Giuseppe Spinozzi, Federica Ornati, Cecilia Canzonieri, Carla Olivieri, Cesare Danesino, Marco Benazzo, Rosangela Invernizzi

Blood (2012) 120 (21): 629.

https://doi.org/10.1182/blood.V120.21.629.629

Published: 2012

Journal Articles

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

David B. Sykes, MD, PhD, Wilfried A. Schroyens, MD, PhD, Casey L. O'Connell, MD, Donald I. Feinstein, MD, Hasan Bazari, MD, Douglas M. Dahl, MD, Robert B. Colvin, MD, Bernard P. Paelinck, MD, PhD, Raul N. Uppot, MD, Bart Op de Beeck, MD, William Boswell, MD, Noopur S. Raje, MD, Nancy Lee Harris, MD, Eyal C. Attar, MD

Blood (2011) 118 (21): 1037.

https://doi.org/10.1182/blood.V118.21.1037.1037

Published: 2011

Journal Articles

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

Gizem Tumer, MD, Tiffany Jow, BS, W. Clark Lambert, MD, PhD

Blood (2011) 118 (21): 5176.

https://doi.org/10.1182/blood.V118.21.5176.5176

Published: 2011

Journal Articles

Bevacizumab Rapidly and Completely Corrects Massive Transfusion Requirement In a Patient with Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Donald Busiek, MD, Keith Bernstein, M.D.

Blood (2010) 116 (21): 2118.

https://doi.org/10.1182/blood.V116.21.2118.2118

Published: 2010

Journal Articles

Malignancies and Outcome in Patients with Ataxia-Telangiectasia: Results From the French National Registry for Primary Immune Deficiencies.

Felipe Suarez, MD, PhD, Julien Beauté, MD, MPH, NIzar Mahlaoui, MD, MSc, Romain Micol, MD, MPH, Olivier Hermine, MD, PhD, Dominique stoppa-Lyonnet, MD, PhD, Alain Fischer, MD, PhD

Blood (2009) 114 (22): 1101.

https://doi.org/10.1182/blood.V114.22.1101.1101

Published: 2009

Journal Articles

Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia

Antonios Kattamis, MD, Christina Lazaropoulou, BSc, Maria Siopi, BSc, Ino Kanavaki, MD, Evgenios Goussetis, MD, Vassilios Ladis, MD, Ioannis Papassotiriou, PhD

Blood (2008) 112 (11): 5408.

https://doi.org/10.1182/blood.V112.11.5408.5408

Published: 2008

Journal Articles

Complete Response to Thalidomide and Dexamethasone in a Patient with Necrobiotic Xanthogranuloma (NXG) Associated with Monoclonal Gammopathy of Uncertain Significance (MGUS)

Yvonne A Efebera, MD, Elizabeth Blanchard, MD, Andrew J Han, Charles Allam, MD, Nikhil C. Munshi, MD

Blood (2008) 112 (11): 5210.

https://doi.org/10.1182/blood.V112.11.5210.5210

Published: 2008

Journal Articles

DNA-Dependent Protein Kinase Is a Therapeutic Target in Poor Prognosis B-Cell Chronic Lymphocytic Leukemia

Elaine Willmore, BSc, PhD, Sarah L. Elliott, Clark J. Crawford, Geoffrey Summerfield, Tryfonia Mainou-Fowler, Graham Jackson, Paul Evans, Paula Newton, Duncan Gowans, Barbara W. Durkacz

Blood (2008) 112 (11): 382.

https://doi.org/10.1182/blood.V112.11.382.382

Published: 2008

Journal Articles

Use of Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Prithviraj Bose, MD, Jennifer Holter, MD, George Selby, MD

Blood (2008) 112 (11): 3928.

https://doi.org/10.1182/blood.V112.11.3928.3928

Published: 2008

Journal Articles

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

Anna Guarini, Marilisa Marinelli, Simona Tavolaro, Isabella Torrente, Emanuele Bellacchio, Monia Magliozzi, Simona Santangelo, Nadia Peragine, Maria Stefania De Propris, Mauro Nanni, Sabina Chiaretti, Francesca Romana Mauro, Ilaria Del Giudice, Bruno Dallapiccola, Robert Foa

Blood (2008) 112 (11): 2084.

https://doi.org/10.1182/blood.V112.11.2084.2084

Published: 2008

Journal Articles

HHT is not a TGFβ disease

Sabine Bailly

Blood (2008) 111 (2): 478.

https://doi.org/10.1182/blood-2007-10-118042

Published: 2008

NARROW

The TEMPI syndrome

Incidence of Thromboembolic Disease in Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Causes and Severity of Anemia in Hereditary Hemorrhagic Telangiectasia

Pomalidomide in Hereditary Hemorrhagic Telangiectasia: Interim Results of a Phase I Study

Mexican Patient with Refractory Mycosis Fungoides Successfully Treated with Pralatrexate at Low Doses: Case Report

Histological Characteristics of Ataxia Telangiectasia Associated Lymphoproliferative Diseases. Results of the French Registry of Primary Immune Deficiencies

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

TEMPI: A Reversible Syndrome Following Treatment with Bortezomib

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

Bevacizumab Rapidly and Completely Corrects Massive Transfusion Requirement In a Patient with Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Malignancies and Outcome in Patients with Ataxia-Telangiectasia: Results From the French National Registry for Primary Immune Deficiencies.

Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia

Complete Response to Thalidomide and Dexamethasone in a Patient with Necrobiotic Xanthogranuloma (NXG) Associated with Monoclonal Gammopathy of Uncertain Significance (MGUS)

DNA-Dependent Protein Kinase Is a Therapeutic Target in Poor Prognosis B-Cell Chronic Lymphocytic Leukemia

Use of Bevacizumab in Hereditary Hemorrhagic Telangiectasia

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

HHT is not a TGFβ disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only